ArticleFrontiers in oncology2025

Development and validation of nomogram models for predicting immune-related adverse events in recurrent and metastatic nasopharyngeal carcinoma patients treated with PD-L1 inhibitors.

Mengyuan Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.